Prevalence of Nonalcoholic Fatty Liver Disease in Children with Renal Failure Underwent Treatment with Dialysis

Yahya Madihi, Reza Tavakoli, Maryam Riahinezhad, Neda Mostofizadeh, Mehryar Mehrkash, Noushin Rostampour, Silva Hovsepian

Abstract


Background: In this study, we aimed to investigate the prevalence of nonalcoholic fatty liver disease (NAFLD) in children with renal failure under treatment with dialysis and its association with biochemical measurements. Methods: In this cross‑sectional study, children aged less than 18 years with chronic kidney disease (CKD) who were under treatment with dialysis at least 3 months ago were enrolled. To evaluate fatty liver in those patients who had no recent liver ultrasonography (last 6 months), liver ultrasonography was performed. The characteristics of patients with renal failure with and without NAFLD based on the ultrasonographic evaluation were compared. The association between NAFLD and the studied variables was evaluated. Results: In this study, 39 children (31 males and 8 females) with renal failure who underwent treatment with dialysis were included. From the studied population, six (19.4%) had NAFLD based on ultrasonographic evaluation. There were no differences between renal failure patients with and without NAFLD regarding the biochemical and anthropometric characteristics (P > 0.0). Conclusions: The prevalence of NAFLD in our studied children with renal failure who underwent treatment with dialysis was like the general population and it was not associated with the biochemical and anthropometric characteristics of the patients. Given the importance of NAFLD in renal failure patients as well as its subtle nature, it is recommended to screen patients with CKD for NAFLD.

Keywords


Adolescent; child; nonalcoholic fatty liver disease; renal insufficiency

Full Text:

PDF

References


Masalskienė J, Rudaitis Š, Vitkevič R, Čerkauskienė R, Dobilienė

D, Jankauskienė A. Epidemiology of chronic kidney disease in

children: A report from lithuania. Medicina (Kaunas) 2021;57:112.

Harada R, Hamasaki Y, Okuda Y, Hamada R, Ishikura K.

Epidemiology of pediatric chronic kidney disease/kidney failure:

Learning from registries and cohort studies. Pediatr Nephrol

doi: 10.1007/s00467‑021‑05145‑1.

Eknoyan G, Lameire N, Eckardt K, Kasiske B, Wheeler D,

Levin A, et al. KDIGO 2012 clinical practice guidelines for the

evaluation and management of chronic kidney disease. Kidney

Int 2013;3:5‑14.

Dai L, Golembiewska E, Lindholm B, Stenvinkel P. End‑stage

renal disease, inflammation and cardiovascular outcomes.

Contrib Nephrol 2017;191:32‑43.

Di Sessa A, Umano GR, Cirillo G, Passaro AP, Verde V,

Cozzolino D, et al. Pediatric nonalcoholic fatty liver disease

and kidney function: Effect of HSD17B13 variant. World J

Gastroenterol 2020;26:5474‑83.

Di Sessa A, Guarino S, Passaro AP, Liguori L, Umano GR,

Cirillo G, et al. NAFLD and renal function in children: Is there a

genetic link? Expert Rev Gastroenterol Hepatol 2021;15:975‑84.

Targher G, Bertolini L, Rodella S, Zoppini G, Lippi G, Day C,

et al. Nonalcoholic fatty liver disease is independently associated

with an increased prevalence of chronic kidney disease and

proliferative/laser‑treated retinopathy in type 2 diabetic patients.

Diabetologia 2008;51:444‑50.

Targher G, Bertolini L, Rodella S, Lippi G, Zoppini G,

Chonchol M. Relationship between kidney function and liver

histology in subjects with nonalcoholic steatohepatitis. Clin J Am

Soc Nephrol 2010;5:2166‑71.

Targher G, Bertolini L, Chonchol M, Rodella S, Zoppini G,

Lippi G, et al. Nonalcoholic fatty liver disease is independently

associated with an increased prevalence of chronic kidney

disease and retinopathy in type 1 diabetic patients. Diabetologia

;53:1341‑8.

Chinnadurai R, Ritchie J, Green D, Kalra PA. Nonalcoholic fatty

liver disease and clinical outcomes in chronic kidney disease.

Nephrol Dial Transplant 2019;34:449‑57.

Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA,

et al. KDOQI US commentary on the 2012 KDIGO clinical

practice guideline for the evaluation and management of CKD.

Am J Kidney Dis 2014;63:713‑35.

Singal AK, Hasanin M, Kaif M, Wiesner R, Kuo Y‑F.

Nonalcoholic steatohepatitis is the most rapidly growing

indication for simultaneous liver kidney transplantation in the

United States. Transplantation 2016;100:607‑12.

Behairy MA, Sherief AF, Hussein HA. Prevalence of

nonalcoholic fatty liver disease among patients with non‑diabetic

chronic kidney disease detected by transient elastography. Int

Urol Nephrol 2021;53:2593‑601.

Mikolasevic I, Milic S, Racki S, Zaputovic L, Stimac D,

Radic M, et al. Nonalcoholic fatty liver disease (NAFLD)‑A new

cardiovascular risk factor in peritoneal dialysis patients. Perit

Dial Int 2016;36:427‑32.

Levey AS. A decade after the KDOQI CKD guidelines. Am J

Kidney Dis 2012;60:683‑5.

Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander‑Tetri BA,

Bacon BR. Nonalcoholic steatohepatitis: A proposal for grading

and staging the histological lesions. Am J Gastroenterol

;94:2467‑74.

Yu EL, Schwimmer JB. Epidemiology of pediatric nonalcoholic

fatty liver disease. Clin Liver Dis (Hoboken) 2021;17:196‑9.

Salehisahlabadi A, Khoshgoftar M, Asadi E, Jadidi H. The

prevalence of non-alcoholic fatty liver disease in Iranian

children and adolescents: A systematic review and meta-analysis.

JSUMS.2018;25:486-94.

Choe AR, Ryu DR, Kim HY, Lee HA, Lim J, Kim JS, et al.

Noninvasive indices for predicting nonalcoholic fatty liver disease

in patients with chronic kidney disease. BMC Nephrol 2020;21:50.

Targher G, Chonchol MB, Byrne CD. CKD and nonalcoholic

fatty liver disease. Am J Kidney Dis 2014;64:638‑52.

Mikolasevic I, Orlic L, Zaputovic L, Racki S, Cubranic Z,

Anic K, et al. Usefulness of liver test and controlled attenuation

parameter in detection of nonalcoholic fatty liver disease in

patients with chronic renal failure and coronary heart disease.

Wien Klin Wochenschr 2015;127:451‑8.

Ray L, Nanda SK, Chatterjee A, Sarangi R, Ganguly S.

A comparative study of serum aminotransferases in chronic

kidney disease with and without end‑stage renal disease: Need

for new reference ranges. Int J Appl Basic Med Res 2015;5:31‑5.

Sinn DH, Kang D, Jang HR, Gu S, Cho SJ, Paik SW, et al.

Development of chronic kidney disease in patients with

nonalcoholic fatty liver disease: A cohort study. J Hepatol

;67:1274‑80.

Pacifico L, Bonci E, Andreoli G, Di Martino M, Gallozzi A, De

Luca E, et al. The impact of nonalcoholic fatty liver disease on

renal function in children with overweight/obesity. Int J Mol Sci

;17:1218.